Safe Medicine Act
Latest action · Sep 9, 2021 Referred to the Subcommittee on Oversight and Investigations.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedAug 10, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Safe Medicine Act
This bill addresses issues related to the manufacture of drugs, including essential medicines.
The Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs must jointly develop and implement a strategy to increase the domestic production of essential medicines, medical countermeasures, and critical inputs.
If the Food and Drug Administration determines that a drug or active pharmaceutical ingredient is manufactured in a country that may be producing contaminated drugs or ingredients due to systemic manufacturing-related problems, the labeling for that drug or ingredient must have a boxed warning about the potential for contamination.
For government procurement purposes, the President's authority to waive certain purchasing requirements that discriminate against foreign products may not be used to waive any preferences for goods that are essential medicines, medical countermeasures, or critical inputs.
Cosponsors 1
Members who signed on, in the order they did. All signed on Aug 10, 2021.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-OH | Tim Ryan | Original | Aug 10, 2021 |
Committees 4
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Aug 10, 2021 |
| Health Subcommittee | Referred Aug 11, 2021 | |
| House | Armed Services Committee | Referred Aug 10, 2021 |
| House | Veterans' Affairs Committee | Referred Aug 10, 2021 |
| Oversight and Investigations Subcommittee | Referred Sep 9, 2021 | |
| House | Ways and Means Committee | Referred Aug 10, 2021 |
| Trade Subcommittee | Referred Aug 10, 2021 |
Actions 5
Everything that happened, newest first.
- Sep 9, 2021Referred to the Subcommittee on Oversight and Investigations.
- Aug 11, 2021Referred to the Subcommittee on Health.
- Aug 10, 2021Introduced in House
- Aug 10, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, Veterans' Affairs, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Aug 10, 2021Referred to the Subcommittee on Trade.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 145, August 10, 2021, page H4326.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 5575 | Safe Medicine Act | Reintroduced Bill | Dec 17, 2024 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes.
- Short Title(s) as Introduced
- Safe Medicine Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Cardiovascular and respiratory health
- Chemical and biological weapons
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Emergency medical services and trauma care
- Health
- Health technology, devices, supplies
- Infectious and parasitic diseases
- Manufacturing
- Medical tests and diagnostic methods
- Military medicine
- Military procurement, research, weapons development
- Nuclear weapons
- Public contracts and procurement
- Strategic materials and reserves
- Trade agreements and negotiations
- Veterans' medical care
- Worker safety and health
Text 1
Each version as it was printed, newest first.
- Aug 10, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.